Mitrano Richard J.
Known title: VP Finance & OperationsCIK: 0001785287
Associated companies
Transaction History
| KRRO | ▼ Sell | Open Market | 237 | $126 | 8/21/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 227 | $143 | 8/18/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 230 | $143 | 8/17/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 234 | $157 | 8/16/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 228 | $148 | 8/15/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 238 | $152 | 8/14/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 240 | $154 | 8/11/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 247 | $158 | 8/10/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 238 | $157 | 8/9/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 241 | $161 | 8/8/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 235 | $162 | 8/7/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 220 | $147 | 8/4/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 232 | $130 | 8/3/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 231 | $113 | 8/2/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 238 | $114 | 8/1/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 222 | $111 | 7/31/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 223 | $105 | 7/28/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 227 | $120 | 7/27/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 222 | $118 | 7/26/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 234 | $117 | 7/25/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 234 | $131 | 7/24/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 223 | $136 | 7/21/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 229 | $147 | 7/20/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 228 | $144 | 7/19/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 249 | $139 | 7/18/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 244 | $159 | 7/17/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 148 | $89 | 7/14/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 227 | $89 | 7/13/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 220 | $88 | 7/12/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 228 | $84 | 7/11/2023 | View on chart |
| KRRO | ▲ Buy | Option Exercise | 758 | — | 7/10/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 220 | $81 | 7/10/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 220 | $79 | 7/7/2023 | View on chart |
| KRRO | ▲ Buy | Option Exercise | 758 | — | 7/7/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 224 | $78 | 7/6/2023 | View on chart |
| KRRO | ▲ Buy | Option Exercise | 758 | — | 7/6/2023 | View on chart |
| KRRO | ▲ Buy | Option Exercise | 758 | — | 7/5/2023 | View on chart |
| KRRO | ▼ Sell | Open Market | 2,184 | $3K | 7/6/2022 | View on chart |
| KRRO | ▲ Buy | Option Exercise | 7,500 | — | 7/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Korro Bio Begins Phase 1/2 Trial for KRRO-121
Korrr Bio has begun dosing the first cohort of its Phase 1/2 study for KRRO-121, a therapy aimed at treating hyperammonemia in patients with urea cycle disorders. The initiation of this trial marks a significant milestone in the drug’s development timeline. Analysts continue to hold a $15 price target, reflecting confidence in the program. Current technical data shows the stock trading near its 52‑week low with an RSI of 39.7.
Korro Bio Begins Phase 1/2 Trial for KRRO-121. Korrr Bio has begun dosing the first cohort of its Phase 1/2 study for KRRO-121, a therapy aimed at treating hyperammonemia in patients with urea cycle disorders. The initiation of this trial marks a significant milestone in the drug’s development timeline. Analysts continue to hold a $15 price target, reflecting confidence in the program. Current technical data shows the stock trading near its 52‑week low with an RSI of 39.7.